Olive Leaf Oleuropein Preserves Elastin in Postmenopausal Women
The Mediterranean diet has been linked to better skin for decades, but few clinical studies have explained why at the molecular level. A recent trial zoomed in on one of the diet’s signature ingredients: olive leaves. A standardized olive leaf extract sold as Bonolive, containing 40 percent oleuropein, preserved elastin levels and reduced the skin aging marker pentosidine in postmenopausal women.
What oleuropein is and why it lives in the leaves
Oleuropein is a polyphenol produced by olive trees as a defense compound against pests and fungi. Concentrations are highest in the leaves and drop as fruit ripens. Olive oil contains only a small fraction of the total oleuropein in the tree, so dietary intake cannot match what a standardized extract delivers, which is why supplementation is necessary.
Bonolive is standardized to 40 percent oleuropein. Many commercial olive leaf products sit at 5 to 10 percent, so checking this number on the label is the fastest way to get close to the dose used in clinical work.
Why tracking elastin and pentosidine together matters
This trial is more informative than a generic “wrinkle reduction” readout because it tracked two concrete molecular endpoints. The first is elastin. Elastin is the fiber that gives skin its snap-back property, but after menopause both its synthesis drops and its degradation accelerates in parallel with estrogen decline. In the trial, the Bonolive group showed a gentler decline than placebo. The result is not that elastin went up. It is that less elastin was lost.
The second marker is pentosidine, an advanced glycation end-product (AGE) formed when sugars attach to long-lived structural proteins like collagen and elastin and cross-link them. Glycated fibers lose flexibility, take on a yellow tint and mechanically drive wrinkles. Lower pentosidine in the Bonolive arm is direct evidence that the polyphenol is slowing glycation.
A different lane for postmenopausal skin
Postmenopausal skin care breaks into two broad strategies. One replaces estrogen through HRT, topical hormone products or phytoestrogens. The other supports skin metabolism through pathways unrelated to estrogen. Bonolive sits in the second camp. It does not touch hormonal signaling. It reduces oxidative stress and glycation, protecting the skin’s structural proteins. For women who cannot use HRT because of breast cancer history or estrogen sensitivity, this hormone-independent pathway is a meaningful option.
A few practical notes. Olive leaf extract has a mild blood-pressure-lowering effect, so anyone with low blood pressure or on antihypertensives should check with a physician. Blood glucose lowering has also been reported, which is relevant for people on diabetes medication. Typical intake is 50 to 100 mg of oleuropein, and 250 mg of Bonolive daily is the dose most common in human trials.